Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.217097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Ashu Shah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198-5870, USA. Hauptthemen laut MEDLINE: Gemcitabine, Deoxycytidine, Receptors, CXCR4, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, University of Nebraska Medical Center.
Abstract (Originalsprache)
Gemcitabine is the first-line treatment option for patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC). However, the frequent adoption of resistance to gemcitabine by cancer cells poses a significant challenge in treating this aggressive disease. In this study, we focused on analyzing the role of trefoil factor 1 (TFF1) in gemcitabine resistance in PDAC. Analysis of PDAC TCGA and cell line datasets indicated an enrichment of TFF1 in the gemcitabine-resistant classical subtype and suggested an inverse correlation between TFF1 expression and sensitivity to gemcitabine treatment. The genetic ablation of TFF1 in PDAC cells enhanced their sensitivity to gemcitabine treatment in both in vitro and in vivo tumor xenografts. The biochemical studies revealed that TFF1 contributes to gemcitabine resistance through enhanced stemness, increasing migration ability of cancer cells, and induction of anti-apoptotic genes. We further pursued studies to predict possible receptors exerting TFF1-mediated gemcitabine resistance. Protein-protein docking investigations with BioLuminate software revealed that TFF1 binds to the chemokine receptor CXCR4, which was supported by real-time binding analysis of TFF1 and CXCR4 using SPR studies. The exogenous addition of TFF1 increased the proliferation and migration of PDAC cells through the pAkt/pERK axis, which was abrogated by treatment with a CXCR4-specific antagonist AMD3100. Overall, the present study demonstrates the contribution of the TFF1-CXCR4 axis in imparting gemcitabine resistance properties to PDAC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198-5870, USA.
- Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198-5900, USA.
- Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, Kashmir, India.
- King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198-5870, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198-5950, U…
Förderung
- NCI NIH HHS
- National Institutes of Health
- University of Nebraska Medical Center
Zitieren
APA
Shah, A., Jahan, R., Kisling, S. G., Atri, P., Natarajan, G., Nallasamy, P., Cox, J. L., Macha, M. A., Sheikh, I. A., Ponnusamy, M. P., Kumar, S., & Batra, S. K. (2024). Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217097
Vancouver
Shah A, Jahan R, Kisling SG, Atri P, Natarajan G, Nallasamy P, et al. Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217097
BibTeX
@article{Shah2024,
author = {Shah, Ashu and Jahan, Rahat and Kisling, Sophia G and Atri, Pranita and Natarajan, Gopalakrishnan and Nallasamy, Palanisamy and Cox, Jesse L and Macha, Muzafar A and Sheikh, Ishfaq Ahmad and Ponnusamy, Moorthy P and Kumar, Sushil and Batra, Surinder K},
title = {Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.217097}
}
EUVIMED